Product Details
| Product Name: Semax | CAS No.: 80714-61-0 |
| Min. Order: 10mg | Purity: 99% HPLC |
| Supply Ability: 20kg | Release date: 2025/07/25 |
Semax is a peptide best known for its nootropic, neuroprotective, and neurogenic/neurorestorative properties. It was developed based on the molecular structure of adrenocorticotropic hormone (ACTH). Preliminary research in cells, animal and small-scale human trials show potential benefits and uses of Semax.
In the U.S. and around the world, Semax is the basis for a number of drugs that are used in clinical practice for the treatment of CNS diseases (ischemic brain stroke, dys-circulatory encephalopathy, optic nerve atrophy, etc.) and to enhance adaptability under extreme conditions in healthy persons.
POTENTIAL BENEFITS
Some of the benefits of Semax may include:
Increased attention and short-term memory
Improved Non-proliferative Diabetic Neuropathy
Can help during recovery from Stroke/Hypoxia
Improved Glaucoma Optic Neuropathy
May act as an Analgesic (pain reliever) by inhibiting Enkephalin breakdown
Can be helpful in the treatment of ADHD
Nootropic (cognitive-enhancing) effects
Neuroprotection: may help protect the brain from various types of stress and damage.
Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $120.00 |
VIP2Y
|
HUARONG(GUANGDONG) PHARMACEUTICAL CO.,LTD
|
2026-06-05 | |
| $999.00 |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2026-06-05 | |
|
VIP2Y
|
Watson Biotechnology Co.,Ltd
|
2026-06-05 | ||
|
VIP2Y
|
Shandong Huizhihan Supply Chain Co., Ltd
|
2026-06-05 | ||
| $9.00 |
VIP1Y
|
Guangzhou XinPeptide International Co.,Ltd
|
2026-06-05 | |
| $1.00 |
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-05 | |
|
VIP1Y
|
Shanghai Yimeixin Technology Co., LTD
|
2026-06-05 | ||
| $5.00 |
VIP1Y
|
Shanghai Zheng Peptide Plastic Co., Ltd.
|
2026-06-05 | |
| $160.00 |
VIP2Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2026-06-04 | |
| $28.00 |
VIP1Y
|
Rongchuang International
|
2026-06-04 |

China